Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients With Bone Metastases of Solid Tumor
Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.33.721
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
Pharmaceutical Society of Japan